Most people discover Dupuytren's contracture when a finger starts curling toward the palm and won't straighten. By that point the disease has usually been quietly progressing for years. Here is what is actually happening under the skin, and what the three main treatment options involve.
What is going on in the tissue
Dupuytren's is a fibromatosis - a disease of connective tissue in which cells called myofibroblasts proliferate and lay down abnormal collagen in the palm. Over time this collagen forms rope-like cords that run along the tendons toward the fingers. As the cords shorten and contract, they pull the fingers into a bent position that cannot be fully corrected with normal effort.
It is not a tendon disease, which is a common misconception. The tendons themselves are intact. The problem is the tissue layer (called the palmar fascia) that lies above and around them.
The ring finger and little finger are affected most often. The middle finger is affected occasionally. The thumb and index finger are rarely involved. Both hands can be affected, though usually not to the same degree.
Who gets it
The condition runs strongly in families and is far more common in people of Northern European descent. About 5 percent of the US population has some degree of it by their 50s, rising to around 20 percent by their 80s. Men are affected roughly three to four times more often than women and typically develop it earlier.
Known risk factors include diabetes, epilepsy (and certain anticonvulsant medications), heavy alcohol use, and cigarette smoking. Manual labor has been studied as a risk factor with mixed results - the evidence is not strong enough to call it causative.
How it progresses: the Tubiana classification
Severity is usually described using the Tubiana staging system, which adds up the extension deficit (how many degrees short of fully straight each affected finger is) across all involved finger joints.
| Stage | Total extension deficit | What this typically means |
|---|---|---|
| N | 0 degrees | Nodules or pits present, no contracture |
| I | 1-45 degrees | Mild flexion, finger mostly straightens |
| II | 45-90 degrees | Moderate, finger visibly bent |
| III | 90-135 degrees | Severe, hand function noticeably affected |
| IV | More than 135 degrees | Very severe, finger near fully closed |
Most people seek treatment somewhere in stage II or early stage III, when the contracture is interfering with daily tasks - putting on gloves, shaking hands, placing the hand flat on a table.
The three main treatment options
There is no medication that reverses established Dupuytren's contracture. Once cords have formed and are pulling the fingers down, treatment is procedural. Three options are in routine use, with meaningfully different profiles for recurrence, recovery, and risk.
| Treatment | How it works | Typical recurrence at 5 years | Recovery time | Best suited for |
|---|---|---|---|---|
| Needle aponeurotomy | A needle punctures and weakens the cord until it snaps | 50-65% | Days | Elderly patients, earlier stages, anticoagulated patients |
| Collagenase injection (Xiaflex) | An enzyme dissolves the cord; finger straightened the next day | 35-50% | Days to 2 weeks | Stage I-III, patients wanting to avoid surgery |
| Partial fasciectomy | Surgery removes the cord and diseased fascia | 15-25% | 4-8 weeks | Younger patients, more severe disease, recurrent cases |
Recurrence rates vary by study and by how recurrence is defined - many papers define it as any measurable return of contracture, not necessarily one that requires re-treatment. Functional recurrence (needing another procedure) is lower than the numbers above suggest.
Needle aponeurotomy
This is an office procedure done under local anesthesia. The surgeon uses a hypodermic needle to divide the cord through multiple punctures until it ruptures with manipulation. No incision, minimal scarring. Patients typically return to normal use within days.
The tradeoff is the highest recurrence rate of the three. For elderly patients or those with medical conditions that make surgery riskier, or for earlier-stage disease where the cord is thin and straightforward, it is often the right call.
Collagenase injection
Clostridium histolyticum collagenase (brand name Xiaflex) is injected directly into the cord. The enzyme breaks down collagen over 24 hours. The patient returns the next day and the finger is manipulated straight under local anesthesia. The cord usually ruptures during this maneuver.
Skin tears at the injection site occur in a meaningful minority of patients and need wound care but heal without lasting problems in most cases. Tendon rupture is a rare but reported complication. Collagenase is not available in all countries and insurance coverage varies.
Partial fasciectomy
The most invasive option is also the most durable. Under general or regional anesthesia, the surgeon makes a zigzag incision in the palm and removes the diseased cord and surrounding fascia. Straight fingers at the end of the procedure. The wound heals over several weeks, and hand therapy is usually needed to maintain range of motion and manage scarring.
Nerve and artery injury is the main surgical risk - both structures run close to the diseased tissue in the palm, and recurrent or severe Dupuytren's distorts normal anatomy. An experienced hand surgeon matters here more than in most procedures.
Recovery and return to work
Recovery depends heavily on which treatment you had.
After needle aponeurotomy, most people can use the hand lightly within a day or two. Gripping is limited briefly by soreness. Full work return depends on the job - desk work within days, heavy manual work within a week or two.
After collagenase injection, the skin tears that sometimes occur need wound care for one to three weeks. Otherwise recovery is similar to needle aponeurotomy.
After surgery, expect six to twelve weeks before the hand is fully functional. Splinting is often used at night for several months to prevent the fingers from curling back as the scar matures. Hand therapy sessions help regain range of motion and strength. People with office jobs can often return within two to three weeks. Manual workers typically need four to six weeks minimum.
What to expect long-term
Dupuytren's is a chronic disease, not a curable one. All treatments address the current cords; none prevent new cords from forming elsewhere in the hand. Patients with more aggressive disease (younger onset, both hands affected, Dupuytren's in the feet or knuckle pads) tend to see faster recurrence and may need multiple procedures over time.
When to see a hand surgeon
A nodule or thickening in the palm without any contracture does not usually need treatment - just monitoring. The practical test is the "tabletop test": if you can lay your hand flat on a table, surgery is rarely indicated. When the finger can no longer be placed flat, or when the contracture is affecting daily activities, that is when a hand surgeon's opinion is warranted.
Not all hand surgeons offer all three procedures. It is reasonable to ask specifically about each option and which the surgeon recommends for your particular stage and finger configuration.
